In addition, it was found that the nucleic acid test of respiratory tract (nasopharyngeal swab/sputum) was negative while the digestive tract nucleic acid (fecal/anal swab) was positive in some COVID-19 cases, indicating that the clearance time of 2019-nCoV in digestive tract was later than that in respiratory tract. According to China\'s⟪diagnosis and treatment Plan for pneumonia infected by novel coronavirus (trial seventh Edition) ⟫simple two consecutive respiratory nucleic acid tests (sampling interval of at least 1 day) are taken as discharge criteria \[[@bib2]\]. The risk of false negative discharge and recovery of positive after discharge is relatively high. There have been cases of nasopharyngeal swabs regaining positive in discharged patients in China \[[@bib3]\]. At present, Current criteria for hospital dis-charge or discontinuation of quarantine and continued patient management may need to be reevaluated. Whether the detection of 2019-nCoV nucleic acid in blood and digestive tract (fecal/anal swab) should be included in the discharge criteria in China is worth discussing.

In short, the detection of multiple biological samples of COVID-19 cases can improve the detection rate of 2019-nCoV nucleic acid, guide clinical diagnosis and treatment, reduce the false negative rate of discharged cases, and play a very important role in determining and cutting off the route of transmission and preventing the further development of the epidemic.
